Photo of Josefine Sandström

Josefine Sandström

Senior Research Coordinator

Coordinates SciLifeLab site Linköping and the national infrastructure platform Clinical Genomics, as well as one of the two BKV representatives for environmental audits.

Presentation

Senior coordinator at SciLifeLab

As senior coordinator for SciLifeLab Linköping, I work to facilitate communication between researchers at LiU and SciLifeLab locally and nationally. The mission within SciLifeLab includes linking other research activities and networks within life sciences and health closer together. I am part of the management group for SciLifeLab Linköping, participate in the Infrastructure Group and the steering group for WCMM, DDLS and SciLifeLab at LiU.
Read more about SciLifeLab site Linköping here.

Co-Platform Coordination’s Officer (co-PCO) Clinical Genomics

As a platform coordinator at the SciLifeLab platform Clinical Genomics in Sweden, I support the operations and management team, compile reports, coordinate events, communicate with operations, users and new users, and partners. Here, I have good use for my background in oncology research.
Read more about Clinical Genomics here.

Environmental auditor

As BKV's representative in LiU's environmental audit group, I work systematically according to the Environmental Management System and the ISO 14001:2015 standard. We review LiU's environmental work with the goal of LiU being environmentally certifiable. This means, for example, that each institution must have an environmental action plan with goals and active work that is based on LiU's and the activities' significant environmental aspects. Read more here.

How to contact me

LinkedIn: https://www.linkedin.com/in/josefinesandstr%C3%B6m/ E-mail: josefine.sandstrom@liu.se
Office: Cellbiology house (463) floor 13

SciLifeLab - a research infrastructure

Publications

2024

Josefine Sandström, Jens Bomanson, Gizeh Perez-Tenorio, Carolin Jönsson, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindstrom, Olle Stål (2024) GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer npj Breast Cancer, Vol. 10, Article 78 (Article in journal) Continue to DOI

2021

Josefine Sandström, Alien Balian, Rebecca Lockowandt, Tommy Fornander, Bo Nordenskjöld, Linda Lindstrom, Gizeh Perez Tenorio, Olle Stål (2021) IP6K2 predicts favorable clinical outcome of primary breast cancer Molecular and clinical oncology, Vol. 14, Article 94 (Article in journal) Continue to DOI

2020

Helena Fohlin, Tove Bekkhus, Josefine Sandström, Tommy Fornander, Bo Nordenskjöld, John Carstensen, Olle Stål (2020) Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer Molecular and clinical oncology, Vol. 12, p. 415-420 (Article in journal) Continue to DOI
Helena Fohlin, Tove Bekkhus, Josefine Sandström, Tommy Fornander, Bo Nordenskjöld, John Carstensen, Olle Stål (2020) RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer Oncology Letters, Vol. 19, p. 52-60 (Article in journal) Continue to DOI

2019

Zeljana Magic, Josefine Sandström, Gizeh Perez Tenorio (2019) Ephrin-B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis-free survival in breast cancer International Journal of Oncology, Vol. 55, p. 1275-1286 (Article in journal) Continue to DOI

Environment and sustainability

Organisation

News